NL-OMON42520已完成不适用
Heparin management and hemostatic risk evaluation in patients undergoing pulmonary thrombo-endarterectomy - PTE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Adult subjects (age 18-85 years)
- •Informed consent
排除标准
- •Re-operation
- •Hereditary hemoglobinopathies
研究者
相似试验
招募中
Unknown
Effect of heparin on cardiopulmonary resuscitatioIRCT20240527061913N1Mashhad University of Medical Sciences70
已完成
2 期
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
已完成
不适用
Monitoring heparin anticoagulation in major vascular surgeryHaematology and vascular surgerySurgeryISRCTN87607734Royal Free London NHS Foundation Trust (UK)40
进行中(未招募)
1 期
BENEFIT OF ANTI-COAGULATION THERAPY IN PATIENTS WITH SEPTIC SHOCK.HEPARIN Anticoagulation to improve outcomes in septic shock : the HALO International Phase II RCTMedDRA version: 20.0Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2018-003726-93-GRHELLENIC INSTITUTE FOR THE STUDY OF SEPSIS500
已完成
不适用
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
